arch oncology in st. louis develops innovative cancer-killing technology for antibody therapy
Published 2 years ago • 161 plays • Length 3:41Download video MP4
Download video MP3
Similar videos
-
5:10
novel cancer drug by st. louis startup is designed to uniquely destroy tumors throughout body
-
1:20
(pro)renin receptor: an emerging biomarker and target for fighting cancer
-
52:05
myeloid immunosuppression in the tumor microenvironment characterized by single/multiplex ihc
-
0:40
altogen labs a20 xenograft service lymphoma
-
27:20
total cancer care
-
1:51
allogeneic nkx101 in liver cancer
-
51:49
“the cancer targetome and its application..."
-
7:58
introduction: antibody-based cancer immunotherapy
-
2:06
advancing mhtt as a biomarker in huntington’s disease
-
2:34
impact of conditioning intensity of allo-sct for aml with molecular residual disease
-
3:19
lung cancer biomarker guideline
-
0:49
ln 229 brain cancer xenograft service
-
28:07
allogeneic t cell therapies
-
1:01:35
new frontiers in immuno-oncology for solid tumor treatment
-
35:51
current and future market dynamics in autoimmune indications | informa tokyo seminar
-
1:33
integrinβ-1 in human disease: molecular mechanisms and therapeutic targets
-
0:40
altogen labs hepg2 xenograft service liver cancer